CRO market shift drives SynteractHCR growth as it moves to new facility

By Melissa Fassbender contact

- Last updated on GMT

(Image: SynteractHCR)
(Image: SynteractHCR)

Related tags: Contract research organization

SynteractHCR has moved to a new 38,000 square foot facility in Carlsbad, CA as it looks to fill the mid-market CRO void created by recent consolidation, says CEO.

Since it was founded in 1987, the contract research organization (CRO) has been headquartered in Carlsbad, CA – a “thrivingbiotech community,” ​which Steve Powell, SynteractHCR CEO, said has been good to the company.

We have longstanding customer relationships, and so it made sense to maintain the headquarters there, while also continuing to expand our East Coast presence in Morrisville, NC and grow across our European facilities​,” Powell told

Powell joined SynteractHCR in July​ of this year at which time he told us​ his goal was to ensure continued innovation. The company also added three senior executives​ to its management team in April.

The move the new facility also follows the company’s completed by the private equity firm Amulet Capital Partners, LP. Powell said the firm has been dedicated to growing the company’s business by improving service delivery.

We see an immediate opportunity to fill the mid-market CRO ‘void’ given recent consolidation in the industry​,” added Powell. “We remain true to developing customer relationships that are a match culturally while delivering per expectations, so this shift in the CRO market is one we see as a key growth driver​.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more